On January 18, 2018 Seattle Genetics, Inc. (Nasdaq: SGEN) reported that it will report its fourth quarter and year 2017 financial results on Tuesday, February 6, 2018 after the close of financial markets. Following the results announcement, company management will host a conference call and webcast discussion of the results and provide a general corporate update (Press release, Seattle Genetics, JAN 18, 2018, View Source;p=RssLanding&cat=news&id=2327230 [SID1234523280]). Access to the event can be obtained as follows:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
LIVE access on Tuesday, February 6, 2018
1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time
Telephone 888-778-9065 (domestic) or 719-325-2452 (international); conference ID 9278036
Webcast available at www.seattlegenetics.com in the Investors section
REPLAY access
Telephone replay will be available beginning at approximately 4:30 p.m. PT on Tuesday, February 6, 2018 through 5:00 p.m. PT on Friday, February 9, 2018 by calling 888-203-1112 (domestic) or 719-457-0820 (international); conference ID 9278036
Webcast replay will be available on the Seattle Genetics website at www.seattlegenetics.com in the Investors section